Cooperative Agreement for Data Collection on Antimicrobial Use in Dogs and Cats (UO1) Clinical Trials Not Allowed

FDA announces the availability of fiscal year (FY) 2020 funds to support the collection of data on antimicrobial use in companion animals. The funded data collection efforts are intended to 1) provide needed information on antimicrobial use practices in companion animals (specifically, dogs and cats) and 2) provide important information on data collection methodologies to help optimize long-term strategies for collection and reporting of such data. The cooperative agreement will enable the collection of critical information to support the Center for Veterinary Medicine's goal to foster antimicrobial stewardship in veterinary settings by monitoring antimicrobial use and management practices in companion animals. The data obtained will support efforts to assess potential associations between antimicrobial use practices and antimicrobial resistance.